Onsdag 3 September | 15:41:20 Europe / Stockholm

Prenumeration

Filter arrow-icon
Språk arrow-icon
2025-08-25 08:35:00
Notice of Extraordinary General Meeting in Ortivus AB (publ) on 19 September 2025
The shareholders of Ortivus AB (publ), company registration number 556259-1205, are hereby invited to an Extraordinary General Meeting to be held on Friday, 19 September 2025 at 15:00 CET. The meeting will take place at the Company’s premises, Svärdvägen 19 (3rd floor), Danderyd
2025-08-25 08:30:00
Interim Report for Ortivus AB (publ) for the period January – June 2025
A significant impact for the patient and for the healthcare system as a whole, including its costs
2025-08-25 08:25:00
The Board of Directors of Ortivus AB proposes a fully underwritten rights issue of approximately SEK 54 million
MUST NOT BE PUBLISHED, DISTRIBUTED OR RELEASED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, RUSSIA, SOUTH AFRICA, OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR OTHER MEASURES. PLEASE REFER TO THE ‘IMPORTANT INFORMATION’ SECTION AT THE END OF THIS ...
2025-04-11 09:30:00
The Board of Directors of Ortivus AB withdraws the proposal to the Annual General Meeting on 8 May 2025 regarding authorisation for the Board to issue shares, etc.
The Board of Directors of Ortivus AB has resolved to withdraw its proposal that the Board be granted authorisation by the Annual General Meeting to issue class B shares, etc. The proposal is withdrawn in its entirety
2025-04-11 09:30:00
Ortivus ABs styrelse återkallar förslaget till Årsstämman den 8 maj 2025 om bemyndigande för styrelsen att ge ut aktier m.m.
Styrelsen i Ortivus AB har beslutat att återkalla sitt förslag att styrelsen ska erhålla ett bemyndigande från årsstämman att ge ut B-aktier m.m. Förslaget återkallas i sin helhet